BAM-2101 | CAS#115178-28-4 | biochemical

MedKoo Cat#: 145912 | Name: BAM-2101

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BAM-2101 is an experimental therapeutic compound being investigated for its potential in treating various types of cancer and inflammatory conditions. It operates by inhibiting specific cellular pathways involved in tumor growth, immune response, and inflammation. BAM-2101’s mechanism of action is thought to involve the modulation of key proteins and signaling molecules that regulate cell proliferation and immune system activity. Due to its ability to target multiple aspects of disease progression, BAM-2101 is being studied for its potential use in both oncology and immunology-based therapies.

Chemical Structure

BAM-2101

CAS#115178-28-4

Theoretical Analysis

MedKoo Cat#: 145912

Name: BAM-2101

CAS#: 115178-28-4

Chemical Formula: C19H22N4

Exact Mass: 306.1800

Molecular Weight: 306.41

Elemental Analysis: C, 74.48; H, 7.24; N, 18.29

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

BAM-2101; BAM2101; BAM 2101;

IUPAC/Chemical Name

(6aR,9S,10aR)-9-((1H-imidazol-1-yl)methyl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline

InChi Key

DFHYZNDFVDJYAL-FDQGKXFDSA-N

InChi Code

1S/C19H22N4/c1-22-10-13(11-23-6-5-20-12-23)7-16-15-3-2-4-17-19(15)14(9-21-17)8-18(16)22/h2-6,9,12-13,16,18,21H,7-8,10-11H2,1H3/t13-,16+,18+/m0/s1

SMILES Code

[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN5C=CN=C5)CN2C

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 306.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Ohno S, Koumori M, Adachi Y, Mizukoshi K, Nagasaka M, Ichihara K. Synthesis and structure-activity relationships of new (5R,8S,10R)-ergoline derivatives with antihypertensive or dopaminergic activity. Chem Pharm Bull (Tokyo). 1994 Oct;42(10):2042-8. doi: 10.1248/cpb.42.2042. PMID: 7805128.